To predict future tau protein burden, Damasceno and colleagues [37] conducted an 18-month follow-up study on 60 mild cognitive impairment (MCI) patients and 28 AD patients, collecting longitudinal PET scan data for each patient. This evidence concerns the gene MAPT and Alzheimer disease.